SPECTRUM 2027

Agenda

January 14–17, 2027 · Miami, FL

Preliminary — Program subject to change

SPECTRUM 2027

Day 1

Thursday, January 14, 2027

8 AM–10 AM

ABLATION SPECTRUM – SESSION 1

Moderators: Brad Wood & Carolina Lanza

8 AM

Standardization of Ablation in 2027

Luigi Solbiati

8:10 AM

High-Frequency RFA in the Liver

Damian Dupuy

8:20 AM

HCC Ablation: Expanding the Boundaries of Curative-Intent Therapy

Gianpaolo Carrafiello

8:30 AM

Does Approach Matter? Percutaneous, Laparoscopic and Surgical Ablation Compared

Robbert Puijk

8:40 AM

Non-Thermal Ablation in HCC

Prav Peddu

8:50 AM

Long-Term Outcomes for IRE in mCRC: A Transatlantic Multicenter Study

Susan van der Lei

9 AM

Added Value of Local Treatment in Multiple mCRC Liver Metastases

Madelon Dijkstra

9:10 AM

From Minimally Invasive to Noninvasive Ablation in the Liver

Mikhail Silk

9:20 AM

Beyond T1a RCC: Expanding the Renal Ablation Envelope

J. Louis Hinshaw

9:30 AM

Lessons from the REWIRED Study

Tze Wah

9:40 AM

Protective Maneuvers During Renal Ablation

Bente van den Be

9:50 AM

Adrenal Ablation: The Forgotten Frontier

Dylan Lewis

10 AM–10:30 AM

BREAK

10:30 AM–12:30 PM

ABLATION SPECTRUM – SESSION 2

Moderators: Damian Dupuy & Yolanda Bryce

10:30 AM

Lung Ablation: Choosing the Right Energy

Robert Suh

10:40 AM

Microwave Ablation of Colorectal Pulmonary Metastasis

Steve Solomon

10:50 AM

Breast Cryoablation: From Alternative Therapy to an Oncologic Treatment Strategy

Franco Orsi

11 AM

Protecting Nerves and Critical Structures During Ablation

Gloria Hwang

11:10 AM

Pancreatic IRE

Riccardo Inchingolo

11:20 AM

The Difficult Liver Ablation: Tips & Tricks

Chiara Floridi

11:30 AM

Ablation in the Head & Neck: Treating Tumors Where Millimeters Matter

Afshin Gangi

11:40 AM

MRI-Guided Ablation: When Seeing the Tumor Changes How We Treat It

David Woodrum

11:50 AM

Value of Robotics in Image-Guided Ablation Today

Bulent Arslan

12 PM

Robotics in Complex Ablations

Chris Sinsabaugh

12:10 PM

Sarcoma Ablation: Local Control and Immune Effects

Varshana Gurusamy

12:20 PM

Ablation of Desmoid Tumors

Suraj Bhame

12:30 PM–1:50 PM

LUNCH & LEARN

12:30 PM

Sponsored Symposium

1:10 PM

Sponsored Symposium

2 PM–3:10 PM

VIDEO LEARNING

Moderators: Tze Wah & Graham Munneke

2 PM

MedPeers: A Video Learning Resource for Peers

Martijn Meijerink

2:10 PM

Liver Tumors: How to Target, Protect and Ablate

Gianpaolo Carrafiello

2:20 PM

Combining Ablation and TACE

Roberto Iezzi

2:30 PM

Breast Cryoablation: From Targeting to Treatment Confirmation

Yolanda Bryce

2:40 PM

Thermal Ablation Options in RCC

Keith Quencer

2:50 PM

Cone-Beam CT-Guided Renal Ablations

Maria Giovanna Riga

3 PM

Rethinking US Guidance for Percutaneous Interventions

Brad Wood

3:10 PM–4 PM

M&M

Moderators: Govindarajan Narayanan & Chiara Floridi

3:10 PM

When HCC Ablation Doesn't Go According to Plan

Sonia Triggiani

3:20 PM

A Renal Ablation I Would Do Differently Today

J. Louis Hinshaw

3:30 PM

An Ablation Case That Changed My Practice

Merve Ozen

3:40 PM

Too Close for Comfort: MSK Ablation Complication

Dimitrios Filippiadis

3:50 PM

Pancreas Ablation: Complication and Management

Prav Peddu

4 PM–4:30 PM

4:30 PM–6 PM

HANDS-ON WORKSHOP

6:30 PM–8 PM

SOCIAL EVENT

SPECTRUM 2027

Day 2

Friday, January 15, 2027

7 AM–8 AM

ABSTRACT SESSION

8 AM–10 AM

HCC & CHOLANGIOCARCINOMA

Moderators: Bruno Odisio

8 AM

HCC Transplant After Immunotherapy: Are the Boundaries of Transplant Eligibility Changing?

David Levi

8:10 AM

How Immunotherapy Is Changing the HCC Treatment Algorithm

Richard Finn

8:20 AM

Radiation Segmentectomy as Curative Therapy: Has Y-90 Joined the Curative Toolbox?

Robert J. Lewandowski

8:30 AM

Ablation for Early HCC: Choosing the Right Energy

Yilun Koethe

8:40 AM

Beyond TACE Alone: What EMERALD-3 Means for the Interventional Oncologist

William Rilling

8:50 AM

Management of HCC with Portal Vein Thrombosis

Pilar Bayona Molano

9 AM

Resectability in iCCA: When Should Systemic and Local Therapy Lead Back to the Operating Room?

Flavio Rocha

9:10 AM

Precision Oncology in Cholangiocarcinoma: Matching the Molecular Alteration to the Therapy

Caio Max Rocha Lima

9:20 AM

Y-90 + Immunotherapy in iCCA: Can Local Therapy Change Tumor Biology?

Bruno Odisio

9:30 AM

Ablation for iCCA: Is the Evidence Strong Enough to Expand Its Role?

Nadine Abi-Jaoudeh

9:40 AM

Ablative Radiation for iCCA: From Local Control to Conversion Strategy

Lorraine Portelance

9:50 AM

Q&A

10 AM–4:30 PM

BREAK

10 AM

Break

4 PM

Break

10:30 AM–11:30 AM

TUMOR BOARD – HCC & CHOLANGIOCARCINOMA

11:30 AM–12:30 PM

EMBOLIZATION IN IO

Moderators: Keith Horton & Prav Peddu

11:30 AM

Bland Embolization

Wael Saad

11:40 AM

Overview of Liquid Embolics

Carolina Lanza

11:50 AM

Biodegradable Microspheres

Ornella Moschovaki-Zeiger

12 PM

Pressure Modification During Hepatic Tumor Embolization

Venkatesh Krishnasamy

12:10 PM

c-TACE: Technique and Data

Chiara Floridi

12:20 PM

Hemostatic Arterial Interventions in Oncologic Emergencies

Shoban Haridass

12:30 PM–1:50 PM

LUNCH & LEARN

12:30 PM

Sponsored Symposium

1:10 PM

Sponsored Symposium

2 PM–3 PM

BREAST CANCER

Moderators: Reshma Mahtani & Franco Orsi

2 PM

The New Systemic Therapy Landscape: Immunotherapy and Targeted Treatment in Breast Cancer

Reshma Mahtani

2:10 PM

Surgery After Neoadjuvant Therapy: How Response Is Changing Surgery

Nadia Zachariah

2:20 PM

When Is Ablation Appropriate?

Franco Orsi

2:30 PM

Ablation in Breast Cancer: Level of Evidence

Yolanda Bryce

2:40 PM

Tumor Board

3 PM–4 PM

LUNG

Moderators: Robert Suh & Brian Lally

3 PM

Less Is More? Wedge, Segmentectomy or Lobectomy for Early-Stage Lung Cancer

Ian Bostock

3:10 PM

SBRT in Lung Cancer: Have We Reached the Limits or Can We Treat More?

Brian Lally

3:20 PM

Ablation as Definitive Therapy for Stage I NSCLC: What the Evidence Tells Us

Damian Dupuy

3:30 PM

Beyond Stage I NSCLC: The Expanding Role of Ablation in Pulmonary Metastatic Disease

Robert Suh

3:40 PM

Tumor Board

4:30 PM–5:40 PM

MSK

Moderators: Dimitrios Filippiadis & Afshin Gangi

4:30 PM

MSK Interventions: Current and Future Practices

Afshin Gangi

4:40 PM

Radiation + Ablation: Is Combination Therapy Better Than Either Alone for Spine Metastases?

Rupesh Kotecha

4:50 PM

Complex Percutaneous MSK Interventions

Gina Landinez

5 PM

Arterial Therapy for Bone Tumors: From Preoperative Embolization to Treatment Option

Suyash Kulkarni

5:10 PM

Percutaneous Osteosynthesis: When Ablation and Cement Are Not Enough

Jack Jennings

5:20 PM

Percutaneous Solutions for Challenging Pelvic and Sacral Tumors

Dimitrios Filippiadis

5:30 PM

Can Ablation Provide Durable Local Control of Bone Metastases?

Brian Schiro

5:45 PM–6:45 PM

MSK HANDS-ON WORKSHOP

6:45 PM–8 PM

SOCIAL EVENT

SPECTRUM 2027

Day 3

Saturday, January 16, 2027

7 AM–8 AM

ABSTRACT SESSION

8 AM–10 AM

mCRC

Moderators: Luigi Solbiati & Constantinos Sofocleous

8 AM

Systemic Therapy in 2027: Who Are the Right Patients for Liver-Directed Therapy?

Sarbajit Mukherjee

8:10 AM

Modern Resection Strategies for CRLM: How Far Can We Push the Surgical Envelope?

Flavio Rocha

8:20 AM

Optimizing mCRC Ablation: The OPTABLATE Trial

Constantinos Sofocleous

8:30 AM

Beyond COLLISION: The CIEMAR Study

Martijn Meijerink

8:40 AM

The Difficult-to-Ablate CRLM: How I Achieve a Curative Margin

Bruno Odisio

8:50 AM

Building the Future Liver Remnant: PVE, HVD, Radiation Lobectomy or All Three?

Ripal Gandhi

9 AM

Tumor Board

10 AM–4:30 PM

BREAK

10 AM

Break

4:10 PM

Break

10:30 AM–11 AM

JAMES G. CARIDI HONORARY LECTURE

James G. Caridi Honorary Lecture — Bulent Arslan

11 AM–11:30 AM

WOMEN IN IR

Moderators: Gloria Hwang

11 AM

Breaking Barriers and Advancing Science

Tze Wah

11:10 AM

Driving Innovation in IO

Gina Landinez

11:20 AM

Finding Your Voice: From Fellowship to Faculty

Ornella Moschovaki-Zeiger

11:30 AM–12:30 PM

STATE OF THE ART

Moderators: Gianpaolo Carrafiello & Nadine Abi-Jaoudeh

11:30 AM

First in Human: Percutaneous Pancreatic Y-90

Roberto Iezzi

11:40 AM

VR in the Clinical Ablation Workflow

Keith Horton

11:50 AM

Telerobotics in Surgery

Murugesan Manoharan

12 PM

The Sentante Endovascular Robotic System

Constantino Peña

12:10 PM

Remote Image-Guided Tumor Ablation: Now a Reality

Govindarajan Narayanan

12:20 PM

Q&A

12:30 PM–1:50 PM

LUNCH & LEARN

12:30 PM

Sponsored Symposium

1:10 PM

Sponsored Symposium

2 PM–3 PM

VASCULAR INTERVENTIONS & EMBOLIZATIONS IN IO

Moderators: Constantino Peña & Brian Schiro

2 PM

Stratification and Management of PE

Varshana Gurusamy

2:10 PM

Thrombectomy vs. Lysis in the Management of DVT

Oleksandra Kutsenko

2:20 PM

Advances in the Management of Critical Limb Ischemia

Daniela Garcia

2:30 PM

Treatment of Liver Metastases from Uveal Melanoma with Percutaneous Hepatic Perfusion

2:40 PM

Embolization for Sarcoma Liver Metastasis

Graham Munneke

2:50 PM

Splenic Artery Embolization

Ronald Mora

2 PM–4:10 PM

SPECTRUM NEXT

Moderators: Varshana Gurusamy & Mihir Patel

Parallel Session
2 PM

Abstract Presentations

2:30 PM

Residency Pathways in IR

Mihir Patel

2:40 PM

What Do You Look for in an IR Training Program?

Reema Al Rasheed

2:50 PM

Pros and Cons of Practice Models in IR

Thomas Scagnelli

3 PM

Building an IO Practice

Oleksandra Kutsenko

3:10 PM

Research in IO

Koustav Pal

3:20 PM

IR Interest Groups for Medical Students

Nicole Gentile

3:30 PM

Beyond the Exam Room: Can Social Media Change the Future of IR?

Jackie Brenner

3:40 PM

Open Discussion

3 PM–4:10 PM

GU

Moderators: Murugesan Manoharan & J. Louis Hinshaw

3 PM

Beyond Partial Nephrectomy: Modern Surgical Strategies for Complex RCC

Jose A. Karam

3:10 PM

Systemic Is Changing RCC: Where Does Local Therapy Fit?

Rohan Garje

3:20 PM

Where Does Renal Ablation Play a Role as Definitive Therapy?

Tze Wah

3:30 PM

Focal Therapy for Prostate Cancer: Who Should We Treat – and Who Should We Not?

Brad Wood

3:40 PM

Prostate Artery Embolization in Prostate Cancer: From Symptom Control to Oncologic Adjunct

Nainesh Parikh

3:50 PM

PSMA-Guided HIFU Ablation for Prostate Cancer

Manuel Ozambela

4 PM

What's Next in MRI-Guided Therapy in the Prostate?

David Woodrum

4:30 PM–6:30 PM

PANCREAS

Moderators: Flavio Rocha & Martijn Meijerink

4:30 PM

Who Should Receive Aggressive Local Therapy? Reading Tumor Biology After Induction Chemotherapy

Peter Hosein

4:40 PM

The DIRECT Study: Survival Outcomes After IRE for Locally Advanced Pancreatic Cancer

Robert Martin

4:50 PM

Ablative Radiation for Pancreatic Cancer: How Far Can We Push Local Control?

Michael Chuong

5 PM

Image-Guided Local Therapies in Pancreatic Cancer: From IRE to Percutaneous Brachytherapy

Govindarajan Narayanan

5:10 PM

The GANNON Trial: Histotripsy for Pancreatic Cancer – Early Experience

Joan Vidal-Jové

5:20 PM

Targeting the Untargetable: KRAS-Directed Therapy Changes the Landscape in Pancreatic Cancer

Kyaw Aung

5:30 PM

Tumor Board

6:30 PM–9:30 PM

EVENING

6:30 PM

Spectrum 2027 Adjourns

6:45 PM

Reception

7:45 PM

Spectrum Dinner

SPECTRUM 2027

Day 4

Sunday, January 17, 2027

9 AM–10:10 AM

THYROID SPECTRUM

Moderators: Tim Huber & Juan Camacho

9 AM

Management of Thyroid Nodules That Need Treatment: Patient Selection

9:10 AM

Surgery, Surveillance or Ablation? Choosing the Right Treatment for the Right Patient

Neeta Erinjeri

9:20 AM

Thyroid Ablation: From Alternative Treatment to a New Treatment Paradigm

Tim Huber

9:30 AM

Ablation or Embolization? Choosing the Right Minimally Invasive Thyroid Treatment

Alan Sag

9:40 AM

Thyroid Artery Embolization: Patient Selection, Technique and Outcomes

Juan Camacho

9:50 AM

Mastering Thyroid Ablation: Danger Zones, Complication Avoidance and Rescue

Tim Huber

10 AM

Beyond Benign Nodules: Expanding the Frontiers of Thyroid Ablation

Juan Camacho

10:10 AM–10:30 AM

BREAK

10:30 AM–12 PM

HANDS-ON COURSE

12 PM

ADJOURN